Corient Capital Partners, LLC Baxter International Inc Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 17,926 shares of BAX stock, worth $620,956. This represents 0.09% of its overall portfolio holdings.

Number of Shares

17,926

Previous 17,926 -0.0%

Holding current value

$620,956

Previous $1.15 Million -0.0%

% of portfolio

0.09%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$63.83 - $80.0 $153,766 - $192,720	2,409 Added 15.52%	17,926 $1.15 Million
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $31,354 - $36,495	408 Added 2.7%	15,517 $1.2 Million
Q4 2021 Feb 11, 2022	SELL	$74.57 - $87.19 $417,442 - $488,089	-5,598 Reduced 27.03%	15,109 $1.3 Million
Q3 2021 Nov 16, 2021	BUY	$73.77 - $83.61 $121,351 - $137,538	1,645 Added 8.63%	20,707 $1.67 Million
Q2 2021 Aug 16, 2021	BUY	$80.5 - $88.01 $182,171 - $199,166	2,263 Added 13.47%	19,062 $1.53 Million
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $592,097 - $666,904	-7,752 Reduced 31.58%	16,799 $1.42 Million
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $47,344 - $51,722	-628 Reduced 2.49%	24,551 $1.97 Million
Q3 2020 Nov 16, 2020	SELL	$78.33 - $90.73 $69,322 - $80,296	-885 Reduced 3.4%	25,179 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $504,839 - $604,190	6,418 Added 32.67%	26,064 $2.24 Million
Q1 2020 May 06, 2020	BUY	$71.57 - $93.3 $74,289 - $96,845	1,038 Added 5.58%	19,646 $1.6 Million
Q4 2019 Feb 04, 2020	SELL	$76.7 - $88.45 $75,549 - $87,123	-985 Reduced 5.03%	18,608 $1.56 Million
Q3 2019 Nov 06, 2019	BUY	$81.4 - $89.78 $66,015 - $72,811	811 Added 4.32%	19,593 $1.71 Million
Q2 2019 Aug 08, 2019	BUY	$73.44 - $82.41 $34,002 - $38,155	463 Added 2.53%	18,782 $1.54 Million
Q1 2019 May 10, 2019	BUY	$64.48 - $81.31 $71,895 - $90,660	1,115 Added 6.48%	18,319 $1.49 Million
Q4 2018 Feb 07, 2019	SELL	$61.45 - $77.8 $35,210 - $44,579	-573 Reduced 3.22%	17,204 $1.13 Million
Q2 2018 Oct 02, 2018	BUY	$63.43 - $75.41 $15,032 - $17,872	237 Added 1.35%	17,777 $1.31 Million
Q1 2018 May 14, 2018	SELL	$62.56 - $72.26 $1.16 Million - $1.33 Million	-18,469 Reduced 51.29%	17,540 $1.14 Million
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $85,415 - $91,809	-1,390 Reduced 3.72%	36,009 $2.33 Million
Q3 2017 Nov 14, 2017	SELL	$59.5 - $64.61 $74,137 - $80,504	-1,246 Reduced 3.22%	37,399 $0
Q2 2017 Aug 14, 2017	BUY	N/A	575 Added 1.51%	38,645 $2.34 Million
Q1 2017 Aug 17, 2017	BUY	N/A	34,547 Added 980.61%	38,070 $1.97 Million
Q1 2017 Aug 14, 2017	BUY	N/A	3,523	3,523 $204,000

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Baxter International Inc Transaction History